Literature DB >> 2682666

Inactivating the beta 2-microglobulin locus in mouse embryonic stem cells by homologous recombination.

B H Koller1, O Smithies.   

Abstract

We have inactivated, by gene targeting, the endogenous beta 2-microglobulin gene in a mouse embryonic stem cell line. A cloned fragment of the beta 2-microglobulin gene with the coding sequence disrupted by the insertion of the neomycin-resistance gene was used to transfect the embryonic stem cells. G418-resistant colonies were selected and then screened using the polymerase chain reaction to identify those in which the incoming DNA had integrated into the embryonic stem cell genome by homologous recombination. Of a total of 234 G418-resistant colonies screened, 2 correctly targeted colonies were identified. Chimeric mice carrying the inactivated beta 2-microglobulin gene have been obtained from both of these targeted embryonic cell lines. Breeding of offspring from such animals will allow investigation of the effects of homozygous loss of beta 2-microglobulin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2682666      PMCID: PMC298404          DOI: 10.1073/pnas.86.22.8932

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

Review 1.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Germ-line transmission of a planned alteration made in a hypoxanthine phosphoribosyltransferase gene by homologous recombination in embryonic stem cells.

Authors:  B H Koller; L J Hagemann; T Doetschman; J R Hagaman; S Huang; P J Williams; N L First; N Maeda; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium.

Authors:  T C Doetschman; H Eistetter; M Katz; W Schmidt; R Kemler
Journal:  J Embryol Exp Morphol       Date:  1985-06

4.  Evidence for expression of the paternal genome in the two-cell mouse embryo.

Authors:  J A Sawicki; T Magnuson; C J Epstein
Journal:  Nature       Date:  1981-12-03       Impact factor: 49.962

5.  DNA fragments from F9 PyEC mutants increase expression of heterologous genes in transfected F9 cells.

Authors:  E Linney; S Donerly
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

6.  Preservation of hamster oocytes to assay the fertilizing capacity of human spermatozoa.

Authors:  P Quinn; C Barros; D G Whittingham
Journal:  J Reprod Fertil       Date:  1982-09

7.  Mouse major histocompatibility class I gene expression begins at midsomite stage and is inducible in earlier-stage embryos by interferon.

Authors:  K Ozato; Y J Wan; B M Orrison
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

8.  Control of expression of histocompatibility antigens (H-2) and beta 2-microglobulin in F9 teratocarcinoma stem cells.

Authors:  C M Croce; A Linnenbach; K Huebner; J R Parnes; D H Margulies; E Appella; J G Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

9.  Linkage of beta 2-microglobulin and ly-m11 by molecular cloning and DNA-mediated gene transfer.

Authors:  D H Margulies; J R Parnes; N A Johnson; J G Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

10.  Structure of wild-type and mutant mouse beta 2-microglobulin genes.

Authors:  J R Parnes; J G Seidman
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

View more
  63 in total

Review 1.  Once a killer, always a killer: from cytotoxic T cell to memory cell.

Authors:  Leo Lefrançois; Joshua J Obar
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Targeting of the T-cell receptor zeta-chain gene in embryonic stem cells: strategies for generating multiple mutations in a single gene.

Authors:  P E Love; M L Tremblay; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

3.  T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Authors:  X Yang; R Brunham
Journal:  Can J Infect Dis       Date:  1998-03

4.  Transfection of primary embryonic chicken retinal cells using cationic lipid.

Authors:  Yi-Wen Hsieh; Xian-Jie Yang
Journal:  Methods Mol Biol       Date:  2012

Review 5.  Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice.

Authors:  P Höglund; H G Ljunggren; K Kärre; G Jay
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

6.  A bacterial model system for chromosomal targeting.

Authors:  L C Huang; E A Wood; M M Cox
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

7.  Homologous recombination in hybridoma cells: dependence on time and fragment length.

Authors:  M J Shulman; L Nissen; C Collins
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

Review 8.  Deconstructing and reconstructing the mouse and human early embryo.

Authors:  Marta N Shahbazi; Magdalena Zernicka-Goetz
Journal:  Nat Cell Biol       Date:  2018-07-23       Impact factor: 28.824

9.  Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.

Authors:  Y Dai; E M Schwarz; D Gu; W W Zhang; N Sarvetnick; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

10.  Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.

Authors:  V E Laubach; E G Shesely; O Smithies; P A Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.